1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma
    Journal Article

    Motzer, R.; Alekseev, B.; Rha, S. Y.; Porta, C.; Eto, M.; Powles, T.; Grünwald, V.; Hutson, T. E.; Kopyltsov, E.; Méndez-Vidal, M. J.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • The spectrum of benefit from checkpoint blockade in hypermutated tumors
    Research Letter

    Rousseau, B.; Foote, M. B.; Maron, S. B.; Diplas, B. H.; Lu, S.; Argilés, G.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Editorial

    Zauderer, M. G.
    Nature Communications (2021)

    Fulltext@MSK | Save
  • AKT1 E17K inhibits cancer cell migration by abrogating β-catenin signaling
    Journal Article

    Gao, S. P.; Kiliti, A. J.; Zhang, K.; Vasani, N.; Mao, N.; Jordan, E.; Wise, H. C.; Shrestha Bhattarai, T.; Hu, W.; Dorso, M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): A multicentre, open-label, randomised, phase 3 trial
    Journal Article

    Bellmunt, J.; Hussain, M.; Gschwend, J. E.; Albers, P.; Oudard, S.; Castellano, D.; Daneshmand, S.; Nishiyama, H.; Majchrowicz, M.; Degaonkar, V.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • RETRACTED: Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): One cohort of a phase 2, multicentre, open-label, non-comparative study
    Journal Article

    Rugo, H. S.; Lerebours, F.; Ciruelos, E.; Drullinsky, P.; Ruiz-Borrego, M.; Neven, P.; Park, Y. H.; Prat, A.; Bachelot, T.; Juric, D.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Initiation and termination of dialysis in older patients with advanced cancer: Providing guidance in a complicated situation
    Review

    Sprangers, B.; Van der Veen, A.; Hamaker, M. E.; Rostoft, S.; Latcha, S.; Lichtman, S. M.; de Moor, B.; Wildiers, H.
    The Lancet Healthy Longevity (2021)

    Fulltext@MSK | Save
  • Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: A randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
    Journal Article

    Lee, N. Y.; Ferris, R. L.; Psyrri, A.; Haddad, R. I.; Tahara, M.; Bourhis, J.; Harrington, K.; Chang, P. M. H.; Lin, J. C.; Razaq, M. A.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Prognosis of incidental brain metastases in patients with advanced renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Flippot, R.; Nortman, T.; Guida, A.; Patil, S.; Escudier, B.; Motzer, R. J.; Albiges, L.; Voss, M. H.
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Pancreas cancer: Therapeutic trials in metastatic disease
    Review

    Smithy, J. W.; O'Reilly, E. M.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save